SkinBioTherapeutics will "continue to be flexible enough to adapt to opportunities" - Stuart Ashman Chief Executive, Skinbiotherapeutics 00:00:00
Stuart has over 20 years’ experience in the medical device and life science sectors and most recently was CEO of Onbone Oy (“Onbone”), a Finnish private equity-backed medical device company. In this role, he successfully established a global sales force and distribution network and led the growth of a multi-million pound business.
